Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
210 Leser
Artikel bewerten:
(0)

UBM Offers a Preview of the 5th Annual Strategies in Pharma Outsourcing Conference

AMSTERDAM, March 13, 2012 /PRNewswire/ -- Leading events organiser UBM Conferences, a division of UBM Plc (LSE: UBM), has announced details of the 5th Annual Strategies in Pharma Outsourcing conference to be held from 24-25 April 2012 at the Movenpick Hotel Berlin in Germany. The Strategies in Pharma Outsourcing conference is the market-leading forum for the pharmaceutical outsourcing community, providing attendees with a platform to discover new partnership models and contracting strategies, while learning how to enhance pre-clinical, clinical and commercial development in an ultra competitive industry. 2012 will feature a high-level speaker line-up that will offer first-hand insight and expert analysis in selecting, establishing and managing successful contract partnerships and alliances. Speakers include executives from companies including Merck, Teva, AstraZeneca, Wockhardt, Bayer, Pfizer, Novartis, Shire and Eisai and more. The conference will also feature a bonus half-day pre-conference programme running one day prior on 23rd April.

CPhI Conferences Manager, Hayley McLinden, commented that, "The Strategies in Pharma Outsourcing conference brings a different perspective to attendees. The presentations throughout the conference highlight strategies for effective portfolio management, a secure supply chain, IP and patent protection, the creation of successful long-term partnerships and more. These are all key components for finding success in the changing pharma market." She further noted that, "the differentiating factor of this conference comes from the fact that industry colleagues are presenting this information. These are the people that have quality first-hand insight on using CMOs and CROs for Biopharma and can offer a knowledgeable look at the strategic and operational future of contract manufacturing and research. The end goal here is to offer an event that will create value and help attendees maximize their ROI."

The Strategies in Pharma Outsourcing conference programme will run in a conference format with a range of content-rich educational sessions and high-impact networking sessions. The pre-conference programme on 23 April will run as a half day agenda focused on all aspects of the supply chain and value chain and will include two networking and refreshment sessions. The two full day agendas will each begin with state of the market addresses followed by break out tracks focused on either contract manufacturing outsourcing (CMO) or contract research outsourcing (CRO). After a catered networking lunch, the conference will then head into an afternoon of industry relevant learning and networking for both the CMO and CRO sectors.

Topics will include the realities of the changing market, creating a secure supply chain, quality and integrity of supply, successful partnership creation and management and more over the two days. To learn more about the Strategies in Pharma Outsourcing Conference, and to register to attend, please visit: www.cphi-outsourcing.com

To learn more about the full CPhI Conferences line-up, please visit: http://www.cphiconferences.com/

Notes for Editors:

UBM Conferences is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmconferences.com.

SOURCE UBM Conferences

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.